In addition, the clinical outcomes (disease-free survival rate and overall survival rate) of the TCGA breast cancer patients (including luminal A and B) with high expression levels of COPS5 appeared to be poorer (Supplementary Fig. 1a,b). The gene discussed is COPS5; the disease is breast cancer.